Hernan Picard

Hernan Picard is a seasoned professional in clinical development and medical sciences, currently engaged in consultancy and biotech startup creation at BioBridges since October 2024. Previously, Hernan served as Vice President and Head of Global Medical Sciences at Mitsubishi Tanabe Pharma America, overseeing a portfolio of rare diseases including dermatological, neurological, and metabolic conditions. Hernan has held significant leadership roles in clinical development at Alector, Amgen, and Eli Lilly and Company, focusing on neurology, inflammation, and pivotal clinical trials for notable therapies such as apremilast and erenumab. Academic qualifications include a PhD in Neuroscience, various degrees in Cognitive Science and Psychiatry, alongside specialized studies in Clinical Development related to Alzheimer's Disease.